Hypogonadism, Male clinical trials at UCSF
1 research study open to eligible people
Hypogonadism in males means the body does not produce enough testosterone. UCSF is studying a testosterone replacement treatment called XYOSTED in young males. Researchers are looking at how safe and effective this treatment is over the course of 52 weeks.
52 Week Study of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
open to eligible males ages 12-17
This is a 52-week open label single arm study to investigate the effects of XYOSTED, as testosterone replacement therapy, on adolescent males with either primary or secondary hypogonadism. The study aims to determine the effectiveness of XYOSTED measured by continuation or induction of puberty in addition to XYOSTED dosage, safety and testosterone levels.
San Francisco, California and other locations
Last updated: